DOCSLIB.ORG

Necrotic Cell Clearance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Necrotic Cell Clearance Cell Death and Differentiation (2010) 17, 381–397 & 2010 Macmillan Publishers Limited All rights reserved 1350-9047/10 $32.00 www.nature.com/cdd Review Molecular mechanisms of late apoptotic/necrotic cell clearance IKH Poon1,2, MD Hulett*,1,2,3 and CR Parish*,1,3 Phagocytosis serves as one of the key processes involved in development, maintenance of tissue homeostasis, as well as in eliminating pathogens from an organism. Under normal physiological conditions, dying cells (e.g., apoptotic and necrotic cells) and pathogens (e.g., bacteria and fungi) are rapidly detected and removed by professional phagocytes such as macrophages and dendritic cells (DCs). In most cases, specific receptors and opsonins are used by phagocytes to recognize and bind their target cells, which can trigger the intracellular signalling events required for phagocytosis. Depending on the type of target cell, phagocytes may also release both immunomodulatory molecules and growth factors to orchestrate a subsequent immune response and wound healing process. In recent years, evidence is growing that opsonins and receptors involved in the removal of pathogens can also aid the disposal of dying cells at all stages of cell death, in particular plasma membrane-damaged cells such as late apoptotic and necrotic cells. This review provides an overview of the molecular mechanisms and the immunological outcomes of late apoptotic/necrotic cell removal and highlights the striking similarities between late apoptotic/necrotic cell and pathogen clearance. Cell Death and Differentiation (2010) 17, 381–397; doi:10.1038/cdd.2009.195; published online 18 December 2009 The immune system is constantly under pressure to accu- phagocytosis.1,2 Not surprisingly, impairment of phagocytosis rately distinguish foreign materials or pathogens (non-self) due to a deficiency in key phagocytic components such as from normal healthy tissues (self), and make an appropriate C1q, one of the first components of the classical complement immune response to non-self molecules through a range of cascade, has been implicated in an increased susceptibility effector mechanisms. It is equally important for the immune to bacterial infection3 as well as in the development of auto- system to distinguish healthy viable cells (self) from dying immune diseases such as systemic lupus erythematosus cells (altered-self) during the course of tissue remodelling or (SLE).4 Therefore, understanding the molecular mechanisms tissue injury to prevent the release of intracellular molecules of phagocytosis will provide new insights into numerous that may damage neighbouring cells or stimulate an immuno- physiological and pathological processes. genic response against self (i.e., an autoimmune response). Under normal physiological conditions, cells of a multi- Professional phagocytes of the innate immune system use cellular organism predominantly die through the well-defined a broad range of germline-encoded receptors and opsonins process known as apoptosis or programmed cell death (see to discriminate viable cells from pathogens and dying cells, Elmore5 for an extensive review). During different stages of and aid the removal of non-self and altered-self through apoptotic cell death, a precise set of morphological and 1John Curtin School of Medical Research, Australian National University, Canberra, 2601, Australia and 2Department of Biochemistry, La Trobe University, Melbourne, 3086, Australia *Corresponding authors: MD Hulett, Department of Biochemistry, La Trobe University, Physical Sciences 4 Building, Kingsbury Drive, Bundoora, Melbourne, 3086, Australia. Tel: þ 61 3 9479 6567; Fax: þ 61 3 9479 2467; E-mail: [email protected] or C Parish, The John Curtin School of Medical Research, The Australian National University, Building 131, Garran Road, Acton, ACT, 0200, Australia. Tel: þ 61 2 6125 2604; Fax: þ 61 2 6125 2337; E-mail: [email protected] 3These authors contributed equally to this work. Keywords: phagocytosis; necrotic cell; apoptotic cell; pathogen Abbreviations: ACAMP, apoptotic cell-associated molecular pattern; b2GPI, b2-glycoprotein I; BAI1, brain-specific angiogenesis inhibitor 1; C4BP, C4b-binding protein; CFHR4, human complement factor H-related protein 4; CR, complement receptors; CRP, C-reactive protein; DAMP, danger-associated molecular pattern; DC, dendritic cell; DNA, deoxyribonucleic acid; ds, double-stranded; EMAP II, endothelial monocyte-activating polypeptide II; FcgR, Fcg receptor; FPR, formyl peptide receptor; GAG, glycosaminoglycan; GlcNAc, N-acetyl-D-glucosamine; HERDS, heterogeneous ectopic ribonucleoprotein-derived structures; HMDDC, human monocyte-derived dendritic cell; HMDM, human monocyte-derived macrophage; HMGB1, high mobility group box 1 protein; HRG, histidine-rich glycoprotein; HS, heparan sulphate; HSP, heat shock protein; HSPG, heparan sulphate proteoglycans; IFN-g, interferon-g; Ig, immunoglobulin; IL, interleukin; ITIM, immunoreceptor tyrosine-based inhibitor motif; LBP, LPS-binding protein; LPC, lysophosphatidylcholine; LPS, lipopolysaccharide; LTA, lipoteichoic acid; MAC, membrane-attack complex; MASP, MBL-associated serine protease; MBL, mannose-binding lectin; MFG-E8, milk fat globular-EGF factor 8 protein; MIP2, macrophage-inflammatory protein-2; MHC, major histocompatibility complex; MSU, monosodium urate; NOD-like, nucleotide-binding oligomerization domain; PAMP, pathogen-associated molecular pattern; PBL, peripheral blood lymphocyte; PCh, phosphocholine; PRM, pattern recognition molecule; PS, phosphatidylserine; PTX3, pentraxin-3; RAGE, receptor for advanced glycation end-products; RIG-like, retinoic acid-inducible gene-I-like; RNA, ribonucleic acid; SAMP, self-associated molecular pattern; SAP, serum amyloid protein; SAP130, spliceosome-associated protein 130; SLE, systemic lupus erythematosus; TCR, T-cell receptor; TFAM, mitochondrial transcription factor A; TGF-b, transforming growth factor-b; TIM, T-cell immunoglobulin mucin; TLR, Toll-like receptor; TNF-a, tumour necrosis factor-a; Trem, triggering receptor expressed on myeloid cells; TSP-1, thrombospondin-1; VEGF, vascular endothelial growth factor Received 18.6.09; revised 30.10.09; accepted 02.11.09; Edited by P Vandenabeele; published online 18.12.09 Mechanisms of late apoptotic/necrotic cell clearance IKH Poon et al 382 biochemical changes occur within the dying cell.5 Dying cells soluble molecules such as lysophosphatidylcholine (LPC),16 can be characterized as early apoptotic cells, in which the endothelial monocyte-activating polypeptide II (EMAP II)17 plasma membrane remains intact but exposes phosphatidyl- and fractalkine/CX3CL118 by early apoptotic cells has also serine (PS) on the cell surface to mediate its recognition by been suggested to promote the recruitment of macrophages phagocytes. Early apoptotic cells can become late apoptotic and monocytes towards cells undergoing apoptosis. Interest- cells, also known as secondary necrotic cells, when the ingly, apoptotic leukocytes (HL-60 cells) generated by heat plasma membrane becomes permeabilized.2 Alternatively, treatment can secret both S19 ribosomal homodimer and a direct exposure of healthy viable cells to trauma, such as serine protease to promote and subsequently retard mono- extreme temperature, mechanical, and chemical insults, can cyte migration, respectively, during the early and later stages lead to the generation of membrane-permeabilized necrotic of apoptotic cell death.19 Besides facilitating the chemotaxis of cells (i.e., primary necrotic cells).6 Importantly, depending on mononuclear phagocytes, induction of apoptosis can also the type of dying cells (e.g., early apoptotic versus necrotic trigger the release of lactoferrin, an anti-inflammatory glyco- cells), recognition and internalization by phagocytes can protein that selectively inhibits the migration of neutrophils result in an anti- or a pro-inflammatory response.1,7 In towards early apoptotic cells, possibly to prevent any aberrant addition, uptake of apoptotic cells by macrophages can inflammation at sites of physiological forms of cell death.20 also promote cell growth8 and wound healing9 through the Although such an elegant phagocyte recruitment system may release of vascular endothelial growth factor (VEGF) and be necessary in mediating efficient clearance of apoptotic transforming growth factor-b (TGF-b), respectively. Thus, the cells at certain tissues, it should be noted that non-profes- process of phagocytosis in mammals not only serves as sional phagocytes, such as fibroblasts, endothelial and an effector mechanism to clear infectious agents, dying cells, epithelial cells, can also contribute to removing adjacent cells or unwanted materials, but also has a fundamental role in undergoing apoptosis (see Majai et al.21 for an extensive determining the subsequent adaptive immune response review).21 towards the phagocytosed materials as well as orchestrating When a phagocyte comes into close proximity to a target the processes of regeneration and angiogenesis at sites cell, the target cell must expose a sufficient level of ‘eat-me’ of tissue injury. Furthermore, phagocytosis of dying cells, signals to trigger phagocytosis. For phagocytes to discrimi- especially early apoptotic cells in an anti-inflammatory nate pathogens from host cells, Janeway22 proposed that a context, has a vital role in maintaining immunological limited number of germline-encoded pattern recognition tolerance against cell-associated antigens.10 molecules (PRMs) are used by the innate immune
Load more

Recommended publications
  • Complement Recognition Pathways in Renal Transplantation
    BRIEF REVIEW www.jasn.org Complement Recognition Pathways in Renal Transplantation Christopher L. Nauser, Conrad A. Farrar, and Steven H. Sacks Medical Research Council Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King’s College London, National Health Service Guy’s and St. Thomas’ Trust, London, United Kingdom ABSTRACT The complement system, consisting of soluble and cell membrane–bound compo- weigh its effect on organ injury and nents of the innate immune system, has defined roles in the pathophysiology of renal rejection with dampening the antimi- allograft rejection. Notably, the unavoidable ischemia-reperfusion injury inherent to crobial functions of the complement sys- transplantation is mediated through the terminal complement activation products tem, such as opsonisation, cell lysis, and C5a and C5b-9. Furthermore, biologically active fragments C3a and C5a, produced recruitment of neutrophils and other in- during complement activation, can modulate both antigen presentation and T cell flammatory cells.7 It is our belief that priming, ultimately leading to allograft rejection. Earlier work identified renal tubule therapeutic strategies can be designed cell synthesis of C3, rather than hepatic synthesis of C3, as the primary source of C3 to specificallytargetthekeyinitiators driving these effects. Recent efforts have focused on identifying the local triggers of of complement activation at the relevant complement activation. Collectin-11, a soluble C-type lectin expressed in renal tis- location, such as complement-binding sue, has been implicated as an important trigger of complement activation in renal anti-HLA antibodies in the vascular tissue. In particular, collectin-11 has been shown to engage L-fucose at sites of compartment or the initiator(s) of local ischemic stress, activating the lectin complement pathway and directing the innate complement activation in the extravas- immune response to the distressed renal tubule.
    [Show full text]
  • Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia
    BASIC RESEARCH www.jasn.org Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia Yoshiyasu Ueda,1 Takashi Miwa,1 Damodar Gullipalli,1 Sayaka Sato,1 Daisuke Ito,1 Hangsoo Kim,1 Matthew Palmer,2 and Wen-Chao Song1 Departments of 1Systems Pharmacology and Translational Therapeutics and 2Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania ABSTRACT Background Properdin (P) is a positive regulator of the alternative pathway of complement activation. Although P inhibition is expected and has been shown to ameliorate the alternative pathway of comple- ment-mediated tissue injury in several disease models, it unexpectedly exacerbated renal injury in a murine model of C3 glomerulopathy. The role of P in atypical hemolytic uremic syndrome (aHUS) is uncertain. Methods We blocked P function by genetic deletion or mAb-mediated inhibition in mice carrying a factor H (FH) point mutation, W1206R (FHR/R), that causes aHUS and systemic thrombophilia with high mortality. Results Pdeficiency completely rescued FHR/R mice from premature death and prevented thrombocyto- penia, hemolytic anemia, and renal disease. It also eliminated macrovessel thrombi that were prevalent in FHR/R mice. All mice that received a function-blocking anti-P mAb for 8 weeks survived the experimental period and appeared grossly healthy. Platelet counts and hemoglobin levels were significantly improved in FHR/R mice after 4 weeks of anti-P mAb treatment. One half of the FHR/R mice treated with an isotype control mAb but none of the anti-P mAb-treated mice developed stroke-related neurologic disease. Anti-P mAb-treated FHR/R mice showed largely normal renal histology, and residual liver thrombi were detected in only three of 15 treated mice.
    [Show full text]
  • Activation Regulates Alternative Pathway Complement Necrotic
    Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation This information is current as of September 27, 2021. Wei Xu, Stefan P. Berger, Leendert A. Trouw, Hetty C. de Boer, Nicole Schlagwein, Chantal Mutsaers, Mohamed R. Daha and Cees van Kooten J Immunol 2008; 180:7613-7621; ; doi: 10.4049/jimmunol.180.11.7613 Downloaded from http://www.jimmunol.org/content/180/11/7613 References This article cites 56 articles, 27 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/180/11/7613.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation1,2 Wei Xu,* Stefan P. Berger,* Leendert A.
    [Show full text]
  • Blood Cell Changes in Complement Activation- Related Pseudoallergy
    Eur. J. Nanomed. 2015; 7(3): 233–244 Mini Review Zsófia Patkó* and János Szebeni Blood cell changes in complement activation- related pseudoallergy DOI 10.1515/ejnm-2015-0021 Introduction Received April 13, 2015; accepted May 19, 2015 Complement activation-related pseudoallergy (CARPA), as the name implies, is a non-Ig-E-mediated (pseudo- Abstract: The characteristic physiological changes allergic) hypersensitivity reaction (HSR) that is triggered in complement (C) activation-related pseudoallergy by C activation, or C activation plays a major contributing (CARPA) include thrombocytopenia, leukocytosis and role. CARPA is best known in the context of nanotoxicity, leukopenia with or without compensatory leukocytosis. since nanomedicines, i.e. particulate drugs and agents in In the background of these phenomena it is known that the nano (10−9–10 −6 m) size range often cause such reac- anaphylatoxins, the triggers of CARPA, can activate white tions. As reviewed earlier (1–8), and also discussed in blood cells (WBCs) and platelets, and that this activation other papers of this issue, the phenomenon represents can lead to the binding of these cells to each other and an immune barrier to the clinical use of many promising also to capillary endothelial cells, entailing microthrom- nanomedicines. In essence, CARPA may be perceived as bus formation and circulatory blockage mainly in the pul- a biological stress on blood that arises as a consequence monary and coronary microcirculation. These changes of the similarity of nanomedicines to viruses, between are key contributors to the hemodynamic alterations in which the immune system cannot make difference (8). CARPA, and can lead to anaphylactic shock.
    [Show full text]
  • The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
    cells Review The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring Kamila Puchałowicz * and Monika Ewa Ra´c Department of Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected] Received: 2 July 2020; Accepted: 9 August 2020; Published: 11 August 2020 Abstract: CD36 is a multiligand receptor contributing to glucose and lipid metabolism, immune response, inflammation, thrombosis, and fibrosis. A wide range of tissue expression includes cells sensitive to metabolic abnormalities associated with metabolic syndrome and diabetes mellitus (DM), such as monocytes and macrophages, epithelial cells, adipocytes, hepatocytes, skeletal and cardiac myocytes, pancreatic β-cells, kidney glomeruli and tubules cells, pericytes and pigment epithelium cells of the retina, and Schwann cells. These features make CD36 an important component of the pathogenesis of DM and its complications, but also a promising target in the treatment of these disorders. The detrimental effects of CD36 signaling are mediated by the uptake of fatty acids and modified lipoproteins, deposition of lipids and their lipotoxicity, alterations in insulin response and the utilization of energy substrates, oxidative stress, inflammation, apoptosis, and fibrosis leading to the progressive, often irreversible organ dysfunction. This review summarizes the extensive knowledge of the contribution of CD36 to DM and its complications, including nephropathy,
    [Show full text]
  • Host-Parasite Interaction of Atlantic Salmon (Salmo Salar) and the Ectoparasite Neoparamoeba Perurans in Amoebic Gill Disease
    ORIGINAL RESEARCH published: 31 May 2021 doi: 10.3389/fimmu.2021.672700 Host-Parasite Interaction of Atlantic salmon (Salmo salar) and the Ectoparasite Neoparamoeba perurans in Amoebic Gill Disease † Natasha A. Botwright 1*, Amin R. Mohamed 1 , Joel Slinger 2, Paula C. Lima 1 and James W. Wynne 3 1 Livestock and Aquaculture, CSIRO Agriculture and Food, St Lucia, QLD, Australia, 2 Livestock and Aquaculture, CSIRO Agriculture and Food, Woorim, QLD, Australia, 3 Livestock and Aquaculture, CSIRO Agriculture and Food, Hobart, TAS, Australia Marine farmed Atlantic salmon (Salmo salar) are susceptible to recurrent amoebic gill disease Edited by: (AGD) caused by the ectoparasite Neoparamoeba perurans over the growout production Samuel A. M. Martin, University of Aberdeen, cycle. The parasite elicits a highly localized response within the gill epithelium resulting in United Kingdom multifocal mucoid patches at the site of parasite attachment. This host-parasite response Reviewed by: drives a complex immune reaction, which remains poorly understood. To generate a model Diego Robledo, for host-parasite interaction during pathogenesis of AGD in Atlantic salmon the local (gill) and University of Edinburgh, United Kingdom systemic transcriptomic response in the host, and the parasite during AGD pathogenesis was Maria K. Dahle, explored. A dual RNA-seq approach together with differential gene expression and system- Norwegian Veterinary Institute (NVI), Norway wide statistical analyses of gene and transcription factor networks was employed. A multi- *Correspondence: tissue transcriptomic data set was generated from the gill (including both lesioned and non- Natasha A. Botwright lesioned tissue), head kidney and spleen tissues naïve and AGD-affected Atlantic salmon [email protected] sourced from an in vivo AGD challenge trial.
    [Show full text]
  • Opsonin-Dependent Stimulation of Bovine Neutrophil Oxidative Metabolism by Brucella Abortus Peter C
    Veterinary Microbiology and Preventive Medicine Veterinary Microbiology and Preventive Medicine Publications 2-1988 Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Peter C. Canning U.S. Department of Agriculture Billy L. Deyoe U.S. Department of Agriculture James A. Roth Iowa State University, [email protected] Follow this and additional works at: https://lib.dr.iastate.edu/vmpm_pubs Part of the Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Veterinary Toxicology and Pharmacology Commons The ompc lete bibliographic information for this item can be found at https://lib.dr.iastate.edu/ vmpm_pubs/190. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Veterinary Microbiology and Preventive Medicine at Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Microbiology and Preventive Medicine Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Abstract Nonopsonized Brucella abortus and bacteria treated with fresh antiserum, heat-inactivated antiserum, or normal bovine serum were evaluated for their ability to stimulate production of superoxide anion and myeloperoxidasemediated iodination by neutrophils from cattle. Brucella abortus opsonized with fresh antiserum or beat-inactivated antiserum stimulated production of approximately 3 nmol of 0 2 -/106 neutrophils/30 min. Similarly treated bacteria also stimulated the binding of approximately 4.3 nmol of Nal/ 107 neutrophils/h to protein.
    [Show full text]
  • Are Complement Deficiencies Really Rare?
    G Model MIMM-4432; No. of Pages 8 ARTICLE IN PRESS Molecular Immunology xxx (2014) xxx–xxx Contents lists available at ScienceDirect Molecular Immunology j ournal homepage: www.elsevier.com/locate/molimm Review Are complement deficiencies really rare? Overview on prevalence, ଝ clinical importance and modern diagnostic approach a,∗ b Anete Sevciovic Grumach , Michael Kirschfink a Faculty of Medicine ABC, Santo Andre, SP, Brazil b Institute of Immunology, University of Heidelberg, Heidelberg, Germany a r a t b i c s t l e i n f o r a c t Article history: Complement deficiencies comprise between 1 and 10% of all primary immunodeficiencies (PIDs) accord- Received 29 May 2014 ing to national and supranational registries. They are still considered rare and even of less clinical Received in revised form 18 June 2014 importance. This not only reflects (as in all PIDs) a great lack of awareness among clinicians and gen- Accepted 23 June 2014 eral practitioners but is also due to the fact that only few centers worldwide provide a comprehensive Available online xxx laboratory complement analysis. To enable early identification, our aim is to present warning signs for complement deficiencies and recommendations for diagnostic approach. The genetic deficiency of any Keywords: early component of the classical pathway (C1q, C1r/s, C2, C4) is often associated with autoimmune dis- Complement deficiencies eases whereas individuals, deficient of properdin or of the terminal pathway components (C5 to C9), are Warning signs Prevalence highly susceptible to meningococcal disease. Deficiency of C1 Inhibitor (hereditary angioedema, HAE) Meningitis results in episodic angioedema, which in a considerable number of patients with identical symptoms Infections also occurs in factor XII mutations.
    [Show full text]
  • In Vitro Selection for Adhesion of Plasmodium Falciparum-Infected Erythrocytes to ABO Antigens Does Not Affect Pfemp1 and RIFIN
    www.nature.com/scientificreports OPEN In vitro selection for adhesion of Plasmodium falciparum‑infected erythrocytes to ABO antigens does not afect PfEMP1 and RIFIN expression William van der Puije1,2, Christian W. Wang 4, Srinidhi Sudharson 2, Casper Hempel 2, Rebecca W. Olsen 4, Nanna Dalgaard 4, Michael F. Ofori 1, Lars Hviid 3,4, Jørgen A. L. Kurtzhals 2,4 & Trine Staalsoe 2,4* Plasmodium falciparum causes the most severe form of malaria in humans. The adhesion of the infected erythrocytes (IEs) to endothelial receptors (sequestration) and to uninfected erythrocytes (rosetting) are considered major elements in the pathogenesis of the disease. Both sequestration and rosetting appear to involve particular members of several IE variant surface antigens (VSAs) as ligands, interacting with multiple vascular host receptors, including the ABO blood group antigens. In this study, we subjected genetically distinct P. falciparum parasites to in vitro selection for increased IE adhesion to ABO antigens in the absence of potentially confounding receptors. The selection resulted in IEs that adhered stronger to pure ABO antigens, to erythrocytes, and to various human cell lines than their unselected counterparts. However, selection did not result in marked qualitative changes in transcript levels of the genes encoding the best-described VSA families, PfEMP1 and RIFIN. Rather, overall transcription of both gene families tended to decline following selection. Furthermore, selection-induced increases in the adhesion to ABO occurred in the absence of marked changes in immune IgG recognition of IE surface antigens, generally assumed to target mainly VSAs. Our study sheds new light on our understanding of the processes and molecules involved in IE sequestration and rosetting.
    [Show full text]
  • Reelin Signaling Promotes Radial Glia Maturation and Neurogenesis
    University of Central Florida STARS Electronic Theses and Dissertations, 2004-2019 2009 Reelin Signaling Promotes Radial Glia Maturation and Neurogenesis Serene Keilani University of Central Florida Part of the Microbiology Commons, and the Molecular Biology Commons Find similar works at: https://stars.library.ucf.edu/etd University of Central Florida Libraries http://library.ucf.edu This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more information, please contact [email protected]. STARS Citation Keilani, Serene, "Reelin Signaling Promotes Radial Glia Maturation and Neurogenesis" (2009). Electronic Theses and Dissertations, 2004-2019. 6143. https://stars.library.ucf.edu/etd/6143 REELIN SIGNALING PROMOTES RADIAL GLIA MATURATION AND NEUROGENESIS by SERENE KEILANI B.S. University of Jordan, 2004 A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biomedical Sciences in the College of Medicine at the University of Central Florida Orlando, Florida Spring Term 2009 Major Professor: Kiminobu Sugaya © 2009 Serene Keilani ii ABSTRACT The end of neurogenesis in the human brain is marked by the transformation of the neural progenitors, the radial glial cells, into astrocytes. This event coincides with the reduction of Reelin expression, a glycoprotein that regulates neuronal migration in the cerebral cortex and cerebellum. A recent study showed that the dentate gyrus of the adult reeler mice, with homozygous mutation in the RELIN gene, have reduced neurogenesis relative to the wild type.
    [Show full text]
  • Objectives Complement (C') Complement Proteins Functions Of
    Complement Objectives Foundations of Public Health Identify functions of complement Immunology Recognize the similarities and differences of the three complement pathways Complement Identify important complement components & their functions Identify deleterious effects of complement activation and deficiency 1 2 Complement (C’) Complement Proteins Synthesized in the liver and by several Series of approximately 30 heat-labile proteins cells types (splenic macrophages) Normally inactive in the serum Plays an essential role in Inactive complement proteins known as zymogens inflammation and in facilitating Can be sequentially activated in a antibody effectiveness controlled sequence Amplification of the reaction occurs at each step Severe infections or autoimmune Production of biologically active fragments diseases can result from complement for lysis or killing of the target deficiencies (rare in the population) 3 4 Functions of Complement Functions of Complement Essential role in inflammation Assists antibodies in effector functions (Antibody Dependent Cell- mediated Cytotoxicity- ADCC) Assist in clearing immune complexes Opsonization and facilitation of phagocytosis No antigen specificity 5 6 1 Complement 3 Pathways of Activation Complement Activators Classical Triggered when IgM or certain IgG subclasses bind antigens Alternative (Properdin) Triggered by the deposition of complement protein, C3b, onto microbial surfaces No antibodies required for activation Lectin Triggered by the attachment of plasma mannose-binding lectin (MBL) to microbes No antibodies required for Activators start the domino effect… activation 7 8 Early Steps Late Steps The initial steps vary between pathways Dependent on activating substance C3 convertase quickly forms in all paths to cleave C3 Watch this well-done animation on the activation of complement, the Late steps (after C5 convertase) are same in all pathways steps in the complement pathways, Lead to formation of MAC & the functions of complement.
    [Show full text]
  • Understanding the Complement System
    Understanding the Complement System WHAT IS THE IMMUNE SYSTEM? The immune system is a complex network of organs, cells and proteins which work together to protect the body against infection and disease. WHAT IS THE COMPLEMENT SYSTEM? The complement system is a part of the immune system and is essential to the body’s defense against infection. Classical Pathway Lectin Pathway Alternative Pathway Made up of 3 UNIQUE PATHWAYS (Classical, Lectin and Alternative) Each pathway can become activated to trigger a cascade of protein reactions that initiate an immune response Inflammation Marks pathogen/damaged to detect and eliminate: cells for elimination Bacteria Viruses Inflammation Targeted destruction of damaged cells Dead cells When the complement system is working properly, it is a strong and powerful tool that protects the body against harmful invaders. • brain But when the system is thrown out of • nervous system balance, or dysregulated, the proteins can trigger a dangerous, uncontrolled cascade • blood stream of reactions that attack cells and tissues. • kidneys UNLOCKING THE POTENTIAL OF THE COMPLEMENT SYSTEM Alexion’s pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into transformative medicines. 3 DECADES 20 YEARS of complement of real-world evidence demonstrating the safety inhibition research and power of targeted complement inhibitors Dysregulation of the complement system is a key driver of many devastating diseases. Alexion has paved the way for a new class of medicines that inhibit the complement system, prevent further damage and reduce disease symptoms. Alexion is committed to continue unlocking the potential of the complement system and accelerating the discovery and development of new life-changing therapies for even more patients.
    [Show full text]